Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256622 (US10053456, 1 | US10414761, Example 1 | US10968213...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256627 (US10053456, 6 | US10414761, Example 6 | US10968213...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256635 (US10053456, 14 | US10414761, Example 14 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256636 (US10053456, 15 | US10414761, Example 15 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 730 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256644 (US10053456, 23 | US10414761, Example 23 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256658 (US10053456, 37 | US10414761, Example 37 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.90E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256666 (BDBM256667 | US9487511, 45) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256683 (US10053456, 62 | US10414761, Example 62 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256702 (US10053456, 83 | US10414761, Example 83 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM65039 (BDBM256703 | US10053456, 85 | US10414761, Example ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 810 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256715 (US10053456, 100 | US10414761, Example 100 | US1096...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 820 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256722 (US10053456, 109 | US10414761, Example 109 | US1096...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM65037 (BDBM65038 | US9487511, 71) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM65039 (BDBM256703 | US10053456, 85 | US10414761, Example ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM65039 (BDBM256703 | US10053456, 85 | US10414761, Example ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256632 (US10053456, 11 | US10414761, Example 11 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256636 (US10053456, 15 | US10414761, Example 15 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.90E+4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256640 (US10053456, 19 | US10414761, Example 19 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256641 (US10053456, 20 | US10414761, Example 20 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256644 (US10053456, 23 | US10414761, Example 23 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256652 (US10053456, 31 | US10414761, Example 31 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256666 (BDBM256667 | US9487511, 45) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256668 (US9487511, 47) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256676 (US9487511, 55) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256693 (US10053456, 73 | US10414761, Example 73 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM65039 (BDBM256703 | US10053456, 85 | US10414761, Example ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256726 (US10053456, 121 | US10414761, Example 121 | US1096...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256630 (US10053456, 9 | US10414761, Example 9 | US10968213...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256631 (US10053456, 10 | US10414761, Example 10 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256634 (US10053456, 13 | US10414761, Example 13 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.30E+4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256635 (US10053456, 14 | US10414761, Example 14 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256648 (US10053456, 27 | US10414761, Example 27 | US948751...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256651 (US10053456, 30 | US10414761, Example 30 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256685 (US10053456, 64 | US10414761, Example 64 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256716 (US9487511, 101) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM65037 (BDBM65038 | US9487511, 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM65037 (BDBM65038 | US9487511, 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM256695 (US10053456, 75 | US10414761, Example 75 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM65037 (BDBM65038 | US9487511, 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-B inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK. A test compound... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM256702 (US10053456, 83 | US10414761, Example 83 | US109682...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM50153590 (CHEMBL3774809 | US10053456, 97 | US10414761, Examp...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM50153592 (CHEMBL3774654 | US10053456, 102 | US10414761, Exam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The MAO-A inhibitory activity evaluation described below followed the protocol of MAO-Glo (registered trademark) Assay of Promega KK.A test compound ... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256669 (US9487511, 48) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256711 (US10053456, 93 | US10414761, Example 93 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM65039 (BDBM256703 | US10053456, 85 | US10414761, Example ...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256631 (US10053456, 10 | US10414761, Example 10 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256637 (US10053456, 16 | US10414761, Example 16 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256642 (US10053456, 21 | US10414761, Example 21 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256651 (US10053456, 30 | US10414761, Example 30 | US109682...) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutathione S-transferase P/Lysine-specific histone demethylase 1A [172-833] (Homo sapiens (Human)) | BDBM256659 (US9487511, 38) | PDB UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description A test compound dissolved in DMSO was added by to a reaction solution (50 mM Tris-HCl (pH 8.0), 0.1% BSA, 1 mM DTT) containing LSD1 enzyme, and the m... | US Patent US9487511 (2016) BindingDB Entry DOI: 10.7270/Q2V123Q4 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 375 total ) | Next | Last >> |